Targeting Cancer Metabolic Reprogramming for Cancer Therapy

1,943
Total downloads
9,237
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 06 Jun 2025

Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth

Archana Shrestha
Md Anamul Haque
Prajesh Shrestha
Margarita Lamprou
Seetharama D. Jois
Constantinos M. Mikelis
George Mattheolabakis

doi 10.3389/fddsv.2025.1584801

876 views

REVIEW

Published on 13 May 2025

Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential

Xiaohan Jin
Ni Zhang
Tinghao Yan
Jingyang Wei
Lingli Hao
Changgang Sun
Haibo Zhao
Shulong Jiang

doi 10.3389/fimmu.2025.1573039

2,731 views

REVIEW

Published on 30 Apr 2025

Mitochondrial ribosomal proteins: potential targets for cancer prognosis and therapy

Jianqing Zhu
Na Wen
Wen Chen
Haotian Yu

doi 10.3389/fonc.2025.1586137

1,406 views

ORIGINAL RESEARCH

Published on 07 Jul 2023

The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis

Marion T. J. van den Bosch
Bryony J. Telford
Sanaz Yahyanejad
Thijs de Gunst
Harm C. den Boer
Rogier M. Vos
Chantal L. Duurland
Rianne Biemans
Ludwig J. Dubois
2 more
Michel Janicot

doi 10.3389/fddsv.2023.1181637

1,319 views

Share on

Frontiers in Drug Discovery

Frontiers in Drug Discovery

Anti-Cancer Drugs

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

9,237Topic views
6,252Article views
1,943Article downloads